Abstract
Subarachnoid haemorrhage (SAH) is less frequent than ischaemic stroke or intracerebral haemorrhage, but has a high public health relevance because it can affect young and middle-age adults, has considerable mortality and morbidity, it is treatable and preventable. SAH is traditionally a topic for neurosurgeons. However as endovascular interventions are becoming effective alternatives to surgical treatment, SAH should turn out to be of interest to neurologists, in particular to those devoted to stroke, emergency and neurointensive care.Despite stable incidence, the mortality of SAH has decreased in the last two decades due to better neurosurgical techniques and neurocritical care and to advances in interventional neuroradiological procedures.
We review the recent advances in the clinical and diagnostic aspects of SAH and in the genetics of intracranial aneurysms. A systematic review of the treatment of SAH and grading of the available evidence is included.
Article PDF
Similar content being viewed by others
Avoid common mistakes on your manuscript.
Abbreviations
- SAH:
-
subarachnoid haemorrhage
- RR:
-
relative risk
- OR:
-
odds ratio
- CT:
-
computerized tomography
- CSF:
-
cerebrospinal fluid
- MR:
-
magnetic resonance
- EEG:
-
electroencephalogram
- ECG:
-
electrocardiogram
- WFNSS:
-
World Federation of Neurological Surgeons Scale
- RCT:
-
randomised controlled trial
- ICU:
-
intensive care unit
References
Al-Shari R, White PM, Davenport RJ, Lindsay KW (2006) Subarachnoid haemorrhage. BMJ 333:235–240
Amin-Hanjani S, Ogilvy CS, Barker FG (2004) Does intracisternal thrombolysis prevent vasospasm after aneurysmal subarachnoid hemorrhage? A meta-analysis. Neurosurgery 54:326–334
Anderson C, Ni Mhurchu C, Scott D, Bennett D, Jamrozik K, Hankey G; Australasian Cooperative Research on Subarachnoid Hemorrhage Study Group (2003) Triggers of subarachnoid hemorrhage: role of physical exertion, smoking, and alcohol in the Australasian Cooperative Research on Subarachnoid Hemorrhage Study (ACROSS). Stroke 34:1771–1776
Ballard J, Kreiter KT, Claassen J, Kowalski RG, Connolly ES, Mayer SA (2003) Risk factors for continued cigarette use after subarachnoid hemorrhage. Stroke 34:1859–1863
Barton CW (1988) Subarachnoid haemorrhage presenting as acute chest pain: a variant of le coup de poignard. Ann Emerg Med 17:977–978
Beetham R, UK NEQAS for Immunochemistry Working Group (2004) Recommendations for CSF analysis in subarachnoid haemorrhage. J Neurol Neurosurg Psychiatry 75:528
Brainin M, Barnes M, Baron J-C, Gilhus NE, Hughes R, Selmaj K, Waldemar G (2004) Guidance for the preparation of neurological management guidelines by EFNS scientific task forces – revised recommendations. Eur J Neurol 11:577–581
Brisman JL, Song JK, Newell DW (2006) Cerebral Aneurysms. N Engl J Med 355:928–939
Britz GW (2005) ISAT trial: coiling or clipping for intracranial aneurysms. Lancet 366:783–785
Byrne JV, Boardman P, Ioannidis I, Traill Z (2003) Seizures after aneurismal subarachnoid haemorrhage treated with coil embolization. Neurosurgery 52:545–552
Caeiro L, Menger C, Ferro JM, Albuquerque R, Figueira ML (2005) Delirium in acute subarachnoid haemorrhage. Cerebrovasc Dis 19:31–38
Caeiro L, Menger C, Ferro JM, Albuquerque R, Figueira ML (2003) Psychiatric complications of subarachnoid haemorrhage. Cerebrovasc Dis 16(Suppl 4):116
Casetta I, Granieri E (2004) Subarachnoid haemorrhage presenting as chest pain. Am J Emerg Med 22:227–228
Cheong JJ, Ghinea N, van Gelder JM (2004) Estimating the annual rate of the novo multiple aneurysms: three statistical approaches. Neurosurg Focus 17:E8
Claassen J, Peery S, Kreiter KT, Hirsch LJ, Du EY, Connolly ES, Mayer SA (2003) Predictors and clinical impact of epilepsy after subarachnoid haemorrage. Neurology 60:208–214
Clarke G, Mendelow AD, Mitchell P (2005) Predicting the risk of rupture of intracranial aneurysms based on anatomical location. Acta Neurochir 147:259–263
Dalbasti T, Karabiyikoglu M, Ozdamar N, Oktar N, Cagli S (2001) Efficacy of controlled-release papaverine pellets in preventing symptomatic cerebral vasospasm. J Neurosurg 95:44–50
De Gans K, Nieuwkamp DJ, Rinkel GJ, Algra A (2002) Timing of aneurysm surgery in subarachnoid hemorrhage: a systematic review of the literature. Neurosurgery 50:336–340
Dennis LJ, Claassen J, Hirsch LJ, Emerson RG, Connolly ES, Mayer SA (2002) Nonconvulsive status epilepticus after subarachnoid hemorrhage. Neurosurgery 1136–1144
Dorsch NW (2002) Therapeutic approaches to vasospasm in subarachnoid haemorrhage. Curr Opin Crit Care 8:128–133
Edlow JA (2005) Diagnosis of subarachnoid hemorrhage. Neurocrit Care 2:99–109
Egge A, Waterloo K, Sjoholm H, Solberg T, Ingebrigtsen T, Romner (2001) Prophylactic hyperdynamic postoperative fluid therapy after aneurysmal subarachnoid hemorrhage: a clinical, prospective, randomized, controlled study. Neurosurgery 49:593–605
Feigin V, Parag V, Lawes CM, Rodgers A, Suh I, Wood Wward M, Jamrozik K, Ueshima H, Asian-Pacific Cohort Studies Collaboration (2005) Smoking and elevated blood pressure are the most important risk factors for subarachnoid hemorrhage in the Asia-Pacific region: an overview of 26 cohorts involving 306, 620 participants. Stroke 36:1360–1365
Feigin VL, Anderson N, Rinkel GJ, Algra A, van Gijn, Bennett DA (2005) Corticosteroids for aneurysmal subarachnoid haemorrhage and primary intracerebral haemorrhage. Cochrane Database Syst Rev (3):CD004583
Feigin VL, Anderson CS, Rodgers A, Bennett DA (2002) Subarachnoid haemorrhage occurrence exhibits a temporal pattern – evidence from meta-analysis. Eur J Neurol 9:511–516
Feigin VL, Rinkel GJE, Lawes CM, Algra A, Bennett DA, van Gijn J, Anderson CS (2005) Risk factors for subarachnoid hemorrhage: un updated systematic review of epidemiological studies. Stroke 36:2773–2780
Franz G, Brenneis C, Kampfl A, Pfausler B, Poewe W, Schmutzhard E (2001) Prognostic value of intraventricular blood in perimesencephalic nonaneurysmal subarachnoid hemorrhage. J Comput Assist Tomogr 25:742–746
Gieteling EW, Rinkel GJE (2003) Characteristics of intracranial aneurysms and subarachnoid haemorrhage in patients with policystic kidney disease. J Neurol 250:418–423
Grasso G (2004) An overview of new pharmacological treatments for cerebrovascular dysfunction after experimental subarachnoid hemorrhage. Brain Res Rev 49–63
Hasan D, Lindsay KW, Wijdicks EF, Murray GD, Brouwers PJ, Bakker WH, van Gijn J, Vermeulen M (1989) Effect of fludrocortisone acetate in patients with subarachnoid hemorrhage. Stroke 20:1156–1161
Hijdra A, Braakman R, van Gijn J, Vermeulen M, van Crevel H (1987) Aneurysmal subarachnoid hemorrhage. Complications and outcome in a hospital population. Stroke 18:1061–1067
Hop JW, Rinkel GJE, Algra A, van Gijn J (1997) Case-fatality and functional outcome after subarachnoid hemorrhage. A systematic review. Stroke 28:660–664
Horiuchi T, Tanaka Y, Hongo K (2005) Surgical treatment for aneurismal subarachnoid hemorrhage in the 8th and 9th decades of life. Neurosurgery 56:469–475
Howington JU, Kutz SC, Wilding GE, Awasthi D (2003) Cocaine use as a predictor of outcome in aneurysmal subarachnoid haemorrhage. J Neurosurg 99:271–275
Huang J, van Gelder JM (2002) The probability of sudden death from rupture of intracranial aneurysms: a meta-analysis. Neurosurgery 51:1101–1105
Hughes PD, Becker GJ (2003) Screening for intracranial aneurysms in autosomal dominant polycystic kidney disease. Nephrology 163–170
International Subarachnoid Aneurysm Trial (ISAT) Collaborative Group (2002) International Subarachnoid Aneurysm Trial (ISAT) of neurosurgical clipping versus endovascular coiling in 2143 patients with ruptured intracranial aneurysms: a randomised trial. Lancet 360:1267–1274
Janjua N, Mayer SA (2003) Cerebral vasospasm after subarachnoid hemorrhage. Curr Opin Crit Care 9:113–119
Johnston SC, Higashida RT, Barrow DL, Caplan LR, Dion JD, Hademenos G, Hopkins LN, Molyneux A, Rosenwasser RH, Vinuela F, Wilson CB (2002) Recommendations for the endovascular treatment of intracranial aneurysms. A statement for healthcare professionals from the Committee on Cerebrovascular Imaging of the American Heart Association Council on Cardiovascular Radiology. Stroke 33:2536–2544
Kasuya H, Onda H, Takeshita M, Okada Y, Hori T (2002) Efficacy and safety of nicardipine prolonged-release implants for preventing vasospasm in humans. Stroke 33:1011–1015
Kasuya H, Onda H, Sasahara A, Takeshita M, Hori T (2005) Application of nicardipine prolonged-release implants: analysis of 97 consecutive patients with acute subarachnoid hemorrhage. Neurosurgery 56:895–902
Khechinashvili G, Asplund K (2002) Electrocardiographic changes in patients with acute stroke: a systematic review. Cerebrovasc Dis 14:67–76
Koivisto T, Vanninen R, Hurskainen H, Saari T, Hernesniemi J, Vapalahti M (2000) Outcomes of early endovascular versus surgical treatment of ruptured cerebral aneurysms. A prospective randomised study. Stroke 31:2369–2377
Komiyama M, Yasui T, Sumimoto T, Fu Y (1997) Spontaneous spinal subarachnoid hematoma of unknown pathogenesis: case reports. Neurosurgery 41:691–694
Kreitschmann-Andermahr I, Hoff C, Saller B, Niggemeier S, Pruemper S, Hutter BO, Rohde V, Gressner A, Matern S, Gilsbach JM (2004) Prevalence of pituitary deficiency in patients after aneurysmal subarachnoid hemorrhage. J Clin Endocrinol Metab 89:4986–4992
Krishnamoorthy T, Fiorelli (2006) MR detection of intracranial hemorrhage. In: von Kummer R and Back T (eds) Magnetic resonance imaging in ischemic stroke. Springer, Berlin, pp 165–166
Landtblom A-M, Fridriksson S, Boivie J, Hilman J, Johansson G, Johansson I (2002) Sudden onset headaches: a prospective study of features, incidence and causes. Cephalalgia 22:354–360
Lee KH, Lukovits T, Friedman JA (2006) “Triple-H” therapy for cerebral vasospasm following subarachnoid hemorrhage. Neurocrit care 4:68–76
Liebenberg WA, Worth R, Firth GB, Olney J, Norris JS (2005) Aneurysmal subarachnoid hemorrhage: guidance in making the correct diagnosis. Postgrad Med J 81:470–473
Linn FH, Rinkel GJE, van Gijn J (1996) Incidence of subarachnoid haemorrhage: role of region, year, and rate of computed tomography: a meta-analysis. Stroke 27:625–629
Lozier AP, Connoly ES, Lavine SD, Solomon RA (2002) Gugliemi detachable coil embolization of posterior circulation aneurysms. A systematic review of the literature. Stroke 33:2509–2518
Lubicz B, Leclerc X, Gauvrit J-Y, Lejeune J-P, Pruvo J-P (2004) Endovascular treatment of ruptured intracranial aneurysms in elderly people Am J Neuroradiol 25:592–595
Lysakowski C, Walder B, Costanza MC, Tramer MR (2001) Transcranial Doppler versus angiography in patients with vasospasm due to a ruptured cerebral aneurysm: a systematic review. Stroke 32:2292–2298
Macrea LM, Tramer MR, Walder B (2004) Spontaneous subarachnoid haemorrhage and serious cardiopulmonary dysfunction – a systematic review. Resuscitation 65:139–148
Manno EM (2004) Subarachnoid hemorrhage. Neurol Clin N Am 22:347–366
McCarron MO, Alberts MJ, McCarron P (2004) A systematic review of Terson’s syndrome: frequency and prognosis after subarachnoid haemorrhage. J Neurol Neurosurg Psychiatry 75:491–493
Mees SMD, Rinkel GJE, Hop JW, Algra A, van Gijn J (2003) Antiplatelet therapy in aneurysmal subarachnoid hemorrhage: A systematic review. Stroke 34:2285–2289
Meschia JF, Brott TG, Brow RB (2005) Genetics of cerebrovascular disorders. Mayo Clin Proc 80:122–132
Mitchell P, Gholkar A, Vindlacheruvu RR, Mendelow AD (2004) Unruptured intracranial aneurysms: benign curiosity or ticking bomb? Lancet Neurol 3:85–92
Mitchell P, Wilkinson ID, Hoggard N, Paley MN, Jellinek DA, Powell T, Romanowski C, Hodgson T, Griffiths PD (2001) Detection of subarachnoid haemorrhage with magnetic resonance imaging. J Neurol Neurosurg Psychiatry 70:205–211
Molyneux AJ, Kerr RSC, Yu L-M, Clarke M, Sneade M, Yarnold JA, Sandercock P for the International Subarachnoid Aneurysm Trial (ISAT) Collaborative Group (2005) International Subarachnoid Aneurysm Trial (ISAT) of neurosurgical clipping versus endovascular coiling in 2143 patients with ruptured intracranial aneurysms: a randomised comparison of effects on survival, dependency, seizures, rebleeding, subgroups and aneurysm occlusion. Lancet 366:809–817
Morgan MK, Jonker B, Finfer S, Harrington T, Dorsch NW (2000) Aggressive management of aneurysmal subarachnoid haemorrhage based on a papaverine angioplasty protocol. J Clin Neurosci 7:305–308
Mori T, Katayama Y, Kawamata T, Hirayama T (1999) Improved efficiency of hypervolemic therapy with inhibition of natriuresis by fludrocortisone in patients with aneurysmal subarachnoid hemorrhage. J Neurosurg 91:947–952
Moro N, Katayama Y, Kojima J, Mori T, Kawamata T (2003) Prophylactic management of excessive natriuresis with hydrocortisone for efficient hypervolemic therapy after subarachnoid hemorrhage. Stroke 34:2807–2811
Naidech AM, Janjua N, Kreiter KT, Ostapkovich ND, Fitzsimmons BF, Parra A, Commichau C, Connolly ES, Mayer SA (2005) Predictors and impact of aneurysm rebleeding after subarachnoid haemorrhage. Arch Neurol 62:410–416
Nieuwkamp DJ, de Gans K, Rinkel GJ, Algra A (2000) Treatment and outcome of severe intraventricular extension in patients with subarachnoid or intracerebral hemorrhage: a systematic review of the literature. J Neurol 247:117–121
Nieuwkamp DJ, Rinkel GJE, Silva R, Greebe P, Schokking DA, Ferro JM (2006) Subarachnoid haemorrhage in patients older than 75: clinical course, treatment and outcome. J Neurol Neurosurg Psychiatry 77:933–937
Ohman J, Heiskanen O (1989) Timing of operation for ruptured supratentorial aneurysms: a prospective randomized study. J Neurosurg 70:55–60
Parra A, Kreiter K, Wiliams S, Sciacca R, Mack WJ, Naidech AM, Commichau CS, Fitzsimmons B-F M, Janjua N, Mayer SA, Connoly ES (2005) Effect of prior statin use on functional outcome and delayed vasospasm after acute aneurysmal subarachnoid hemorrhage: a matched case-control study. Neurosurgery 56:476–484
Polin RS, Coenen VA, Hansen CA, Shin P, Baskaya MK, Nanda A, Kassell NF (2000) Efficacy of transluminal angioplasty for the management of symptomatic cerebral vasospasm following aneurysmal subarachnoid hemorrhage. J Neurosurg 92:284–290
Polin RS, Hansen CA, German P, Chadduck JB, Kassell NF (1998) Intra arterially administered papaverine for the treatment of symptomatic cerebral vasospasm. Neurosurgery. 42:1256–1264
Polmear A (2003) Sentinel headaches in aneurysmal subarachnoid haemorrhage. What is the true incidence? A systematic review. Cephalalgia 23:935–941
Reijneveld JC, Wermer M, Bonman Z, van Gijn J, Rinkel GJE (2000) Acute confusional state as presenting feature in aneurysmal subarachnoid haemorrhage. J Neurol 247:112–116
Rinkel GJ, Feigin VL, Algra A van Gijn J (2004) Circulatory volume expansion therapy for aneurysmal subarachnoid haemorrhage. Cochrane Database Syst Rev 18 (4):CD000483
Roman H, Descargues G, Lopes M, Emery E, Clavier E, Diguet A, Freger P, Marpeau L, Proust F (2004) Subarachnoid hemorrhage due to cerebral aneurymal rupture during pregnancy. Acta Obstet Gynecol Scand 83:330–334
Rosen DS, MacDonald RL (2005) Subarachnoid hemorrhage grading scales. Neurocrit Care 2:110–118
Ross Y, Rinkel G, Vermeulen M, Algra A, van Gijn J (2003) Antifibrinolytic therapy for aneurysmal subarachnoid hemorrhage. A major update of a Cochrane review. Stroke 34:2308–2309
Ruigrok YM, Rinkel GJE, Wijmenga C (2005) Genetics of intracranial aneurysms. Lancet Neurol 4:179–189
Sakr YL, Ghosn I, Vincent JL (2002) Cardiac manifestations after subarachnoid hemorrhage a systematic review of the literature. Prog Cardiovasc Dis 4:67–80
Schievink WI, Schaid DJ, Michels VV, Piepgras DG (1995) Familial aneurismal subarachnoid haemorrhage: a community based study. J Neurosurg 83:426–429
Schuiling WJ, Rinkel GJE, Walchenbach R, de Weerd AW (2005) Disorders of sleep and wake in patients after subarachnoid hemorrhage. Stroke 36:578–582
Sedat J, Dib M, Rasendrarijao D, Fontaine D, Lonjon M, Paquis P (2005) Ruptured intracranial aneurysms in the elderly: epidemiology, diagnosis and management. Neurocrit Care 2:119–123
Selo-Ojeme DO, Marshman LAG, Ikomi A, Ojutiku D, Aspoas RA, Chawda SJ, Bawa GPS, Rai MS (2004) Aneurysmal subarachnoid haemorrhage in pregnancy. Eur J Obstet Gynecol Reprod Biol 116:131–143
Sen J, Belli A, Albon H, Morgan L, Petzold A, Kitchen N (2003) Triple-H therapy in the management of aneurysmal subarachnoid haemorrhage. Lancet Neurol 2:614–621
Siironen J, Juvela S, Varis J, Porras M, Poussa K, Ilveskero S, Hernesniemi J, Lassila R (2003) No effect of enoxaparin on outcome of aneurysmal subarachnoid hemorrhage: a randomised, double blind, placebo-controlled clinical trial. J Neurosurg 99:953–959
Singhal AB, Topcuoglu MA, Dorer DJ, Ogilvy CS, Carter BS, Koroshetz WJ (2005) Neurology 64:1008–1013
Slowik A, Borratynska A, Pera J, Betlej M, Dziedzic T, Krzyszkowski T, Czepko R, Figlewicz DA, Szczudlik A (2004) II genotype of the angiotensin-converting enzyme gene increases the risk for subarachnoid hemorrhage from ruptured aneurysm. Stroke 35:1594–1597
Suyama K, Kaminogo M, Yonekura M, Baba H, Nagata I (2005) Surgical treatment of unruptured cerebral aneurysms in the elderly. Acta Neurochir (Suppl)94:97–101
Teasdale GM, Wardlaw JM, White PM, Murray, Teasdale EM, Easton V (2005) The familial risk of subarachnoid haemorrhage. Brain 128:1677–1685
Teunissen LL, Rinkel GJE, Algra A, van Gijn J (1996) Risk factors for subarachnoid hemorrhage. A systematic review. Stroke 27:544–549
The ACROSS Group (2000) Epidemiology of aneurysmal subarachnoid haemorrhage in Australia and New Zealand. Incidence and case-fatality from the Australasian Cooperative Research on Subarachnoid Haemorrhage Study (ACROSS). Stroke 31:1843–1850
The European Stroke Initiative Executive Committee and the EUSI Writing Committee (2003) European Stroke Initiative recommendations for stroke management – update 2003. Cerebrovasc Dis 16:311–337
Thomas JE, McGinnis G (2002) Safety of intraventricular sodium nitroprusside and thiosulfate for the treatment of cerebral vasospasm in the intensive care unit setting. Stroke 33:486–492
Thomé C, Vajkoczy P, Horn P, Bauhuf C, Hübner U, Schmiedek P (2001) Continuous monitoring of regional cerebral blood flow during temporary arterial occlusion in aneurysm surgery. J Neurosurg 95:402–411
Tournier-Lasserve E (2003) Génétique des accidents vasculaires cérébraux. Arch Mal Coeur 96:1105–1110
Toussaint III LG, Friedman JA, Wijdicks EFM, Piepgras DG, Pichelmann MA, McIver JI, McClelland RL, Nichols DA, Meyer FB, Atkinson JLD (2005) Survival of cardiac arrest after aneurysmal subarachnoid hemorrhage. Neurosurgery 57:25–31
Treggiari MM, Walder B, Suter PM, Romand J-A (2003) Systematic review of the prevention of delayed ischemic neurological deficits with hypertension, hypervolemia, and hemodilution therapy following subarachnoid hemorrhage. J Neurosurg 98:978–984
Tseng M-Y, Czosnyka M, Richards H, Pickard JD, Kirkpatrick PJ (2005) Effects of acute treatment with pravastatin on cerebral vasospasm, autoregulation, and delayed ischemic deficits after aneurysmal subarachnoid hemorrhage. A phase II randomised placebo-controlled trial. Stroke 36:1627–1632
Vajoczy P, Meyer B, Weidauer S, Raabe A, Thome C, Ringel F, Breu V, Schmiedek P, and the other study participants (2005) Clazosentan (AXV-034343), a selective endothelin A receptor antagonist, in the prevention of cerebral vasospasm following severe aneurysmal subarachnoid hemorrhage: results of a randomised, double-blind, placebo controlled, multicenter Phase IIa study. J Neurosurg 103:9–17
van der Bergh WM, Algra A, van Kooten F, Dirven CM, van Gijn J, Vermeulen M, Rinkel GJ;MASH Study Group (2005) Magnesium sulphate in aneurysmal subarachnoid hemorrhage: a randomised controlled trial. Stroke 36:1011–1015
van der Schaaf I, Algra A, Wermer M, Molineux A, Clarke M, van Gijn J, Rinkel GJ, Rinkel GM (2005) Endovascular coiling versus neurosurgical clipping for patients with aneurysmal subarachnoid haemorrhage. Cochrane Database Syst Rev (4):CD003085
van Gijn J, Rinkel GJE (2001) Subarachnoid haemorrhage: diagnosis, causes and management. Brain 124:249–278
van Gijn J, van Dongen Vermeulen M, Hijdra A (1985) Perimesencephalic hemorrhage: a nonaneurysmal and benign form of subarachnoid hemorrhage. Neurology 35:493–497
Wardlaw JM, White PM (2000) The detection and management of unruptured intracranial aneurysms. Brain 123:205–221
Water RJ, Nicoll JAR (2005) Genetic influences on outcome following acute neurological insults. Curr Opin Crit Care 11:105–110
Wermer MJH, Buskens E, van der Schaaf, Bossuyt PMM, Rinkel GJE (2004) Yield of screening for new aneurysm after treatment for subarachnoid hemorrhage. Stroke 62:369–375
Wermer MJH, Rinkel GJE, van Gijn J (2003) Repeated screening for intracranial aneurysm in familial subarachnoid hemorrhage. Stroke 34:2788–2791
Whitfield PC, Kirkpatrick PJ (2001) Timing of surgery for aneurysmal subarachnoid haemorrhage. Cochrane Database Syst Rev (2): CD001697
Wijdicks EF, Vermeulen M, van Brummelen P, van Gijn J (1988) The effect of fludrocortisone acetate on plasma volume and natriuresis in patients with aneurysmal subarachnoid hemorrhage. Clin Neurol Neurosurg 90:209–214
Wilby MJ, Sharp M, Whitfield PC, Hutchison PJ, Menon DK, Kirkpatrick PJ (2003) Cost-effective outcome for treating poor-grade subarachnoid hemorrhage. Stroke 34:2508–2511
Winn HR, Richardson AE, Jane JA (1977) The long-term prognosis in untreated cerebral aneurysms: I The incidence of late hemorrhage in cerebral aneurysm: a 10-year evaluation of 364 patients. Ann Neurol 1:358–370
Zubkov YN, Nikiforov BM, Shustin VA (1984) Balloon catheter technique for dilatation of constricted cerebral arteries after aneurysmal SAH. Acta Neurochir 70:65–79
Author information
Authors and Affiliations
Corresponding author
Additional information
Presented at the “Teaching Course on Stroke”, 16th meeting of the European Neurological Society,May 26, 2006, Lausanne
METHODS OF THE REVIEW: information for this review was retrieved from the author’s files and MEDLINE search of the years 2002–2006 using the key words subarachnoid haemorrhage and guidelines, review, epidemiology, genetics, treatment, clinical trials and vasospasm.
Conflicts of interest. The 1st author received travel grants from Bayer (manufacturer of nimodipine) and a research grant from the manufacturer of nicardipine.
Rights and permissions
About this article
Cite this article
Ferro, J.M., Canhão, P. & Peralta, R. Update on subarachnoid haemorrhage. J Neurol 255, 465–479 (2008). https://doi.org/10.1007/s00415-008-0606-3
Received:
Revised:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00415-008-0606-3